|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860.00 KRW | +0.21% |
|
-8.82% | -28.74% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.21% | -8.82% | -28.21% | -38.48% | -28.74% | -52.02% | - | - | - | 74.93M | |
| -1.56% | +4.33% | +11.41% | +13.14% | -1.19% | +32.87% | +326.88% | +104.20% | +1,789.61% | 33.14B | |
| -0.42% | -3.61% | -1.71% | -3.38% | +1.83% | -2.13% | +8.75% | -4.43% | +96.88% | 20.98B | |
| -1.20% | -1.93% | +6.45% | -1.30% | -12.38% | -24.93% | -44.26% | -47.23% | -6.82% | 6.95B | |
| +2.97% | -3.09% | +1.64% | -10.45% | -22.51% | +0.77% | +68.77% | +56.67% | +949.15% | 4.23B | |
| +2.20% | +4.39% | -0.54% | +27.79% | +12.76% | +14.81% | +49.81% | +6.08% | +296.98% | 2.9B | |
| -4.19% | -7.23% | +20.24% | -21.15% | -56.26% | -28.64% | +834.07% | -86.22% | - | 1.75B | |
| +0.12% | -2.61% | -3.98% | -8.17% | -13.19% | -8.65% | -66.59% | -82.58% | - | 1.68B | |
| +7.62% | -0.81% | +8.09% | +5.54% | +23.85% | +44.44% | -24.96% | -47.79% | -34.63% | 1.65B | |
| -1.58% | +0.07% | -4.46% | -3.66% | -0.07% | +13.05% | -4.52% | -40.56% | +19.69% | 1.58B | |
| -2.85% | +2.96% | +5.24% | +46.51% | +24.91% | +42.47% | +180.34% | - | - | 1.49B | |
| +0.40% | +0.68% | +20.96% | +37.84% | -5.06% | +59.27% | -35.24% | -74.85% | +32.92% | 1.45B | |
| -2.22% | +1.85% | +2.21% | +22.53% | +12.08% | +25.39% | +48.48% | -20.65% | - | 1.21B | |
| +1.18% | -6.46% | +0.16% | +1.86% | -6.18% | +0.76% | +13.91% | +11.02% | -29.25% | 1.08B | |
| +0.35% | +1.79% | +12.20% | +23.91% | +13.10% | +12.20% | -11.49% | -62.89% | -84.78% | 1.07B | |
| +0.88% | +3.04% | +15.97% | +54.35% | +22.13% | +62.09% | +209.87% | +24.13% | +182.20% | 911M | |
| +1.13% | -1.37% | +0.84% | -10.92% | -6.99% | +10.97% | +17.51% | -2.71% | +45.64% | 825M | |
| +0.72% | +2.11% | -14.01% | -8.51% | -5.27% | -2.18% | -54.70% | -76.96% | - | 747M | |
| +7.72% | +14.67% | +12.66% | +92.54% | +9.55% | +719.05% | +2,480.00% | - | - | 537M | |
| -2.02% | -4.90% | -3.48% | -21.46% | -23.62% | -14.54% | -40.12% | -61.81% | +33.79% | 517M | |
| Average | +0.49% | -0.63% | +3.08% | +9.93% | -3.06% | +45.25% | +208.24% | -23.92% | +253.18% | 4.24B | |
| Weighted average by Cap. | -0.49% | +0.88% | +5.77% | +7.00% | -2.05% | +18.63% | +167.66% | +31.43% | +857.89% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
